Effects of inducible MEK1 activation on the cytokine dependency of lymphoid cells
- 1 May 2001
- journal article
- research article
- Published by Springer Nature in Leukemia
- Vol. 15 (5) , 794-807
- https://doi.org/10.1038/sj.leu.2402109
Abstract
The Raf/MEK/MAP kinase cascade plays a critical role in transducing growth signals from activated cell surface receptors. Using ΔMEK1:ER, a conditionally active form of MEK1, we demonstrate the ability of this dual specificity protein kinase to abrogate the cytokine dependency of the murine lymphoid hematopoietic cell line FL5.12. Cytokine-independent cells were obtained from FL5.12 cells at a frequency of 1 × 10−7, indicating that a low frequency of cells expressing ΔMEK1:ER were factor-independent. In general, cells that were converted to a cytokine-independent phenotype displayed a higher level of MAP kinase activity in response to ΔMEK1:ER activation than those that remained cytokine-dependent. ΔMEK1:ER-responsive cells could be maintained long-term in the presence of β-estradiol, as well as the estrogen-receptor antagonist 4-hydroxy-tamoxifen. Removal of hormone led to the rapid cessation of cell growth in a manner similar to that observed when cytokine is withdrawn from the parental cells. GM-CSF mRNA transcripts were detected in the MEK1-responsive cells indicating that activated ΔMEK1:ER may induce a pathway leading to autocrine proliferation. Cytokine-dependent ΔMEK1:ER cells were found to increase the expression of GM-CSF receptor α (GM-CSFRα) in response to β-estradiol. In contrast, MEK1-responsive cells were found to express constitutively lower levels of GM-CSFRα and β common (βc) chains indicating that constitutive GM-CSF expression resulted in a decrease in GM-CSFR expression. Treatment of parental cells with supernatant from MEK1-responsive FL5.12 cells was sufficient to promote [3H]-thymidine incorporation. GM-CSF was found to enhance the viability of FL5.12 cells. The cell lines described here will be useful for elaborating the ability of the MAP kinase pathway to regulate cell proliferation in hematopoietic cells.Keywords
This publication has 50 references indexed in Scilit:
- Signal transduction, cell cycle regulatory, and anti-apoptotic pathways regulated by IL-3 in hematopoietic cells: possible sites for intervention with anti-neoplastic drugsLeukemia, 1999
- Differential abilities of activated Raf oncoproteins to abrogate cytokine dependency, prevent apoptosis and induce autocrine growth factor synthesis in human hematopoietic cellsLeukemia, 1998
- Characterization of proteins binding the 3′ regulatory region of the IL-3 gene in IL-3-dependent and autocrine-transformed hematopoietic cellsLeukemia, 1998
- Differential effects of retroviral long terminal repeats on interleukin-3 gene expression and autocrine transformationLeukemia, 1997
- Expression cloning of the human IL-3 receptor cDNA reveals a shared β subunit for the human IL-3 and GM-CSF receptorsCell, 1991
- Growth-promoting effects of insulin-like growth factor-1 (IGF-1) on hematopoietic cells: overexpression of introduced IGF-1 receptor abrogates interleukin-3 dependency of murine factor-dependent cells by a ligand-dependent mechanismBlood, 1991
- CYTOKINES: COORDINATORS OF IMMUNE AND INFLAMMATORY RESPONSESAnnual Review of Biochemistry, 1990
- Establishment and characterization of a unique human cell line that proliferates dependently on GM‐CSF, IL‐3, or erythropoietinJournal of Cellular Physiology, 1989
- Enrichment of hematopoietic precursor cells and cloning of multipotential B-lymphocyte precursors.Proceedings of the National Academy of Sciences, 1985
- Growth of factor-dependent hemopoietic precursor cell lines.The Journal of Experimental Medicine, 1980